References
- 1. Leone P, Vacca A, Dammacco F, et al. Common Variable Immunodeficiency and Gastric Malignancies. Int J Mol Sci 2018;19(2):451. doi:10.3390/ijms1902045110.3390/ijms19020451585567329393912
- 2. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48(13):3554-3560
- 3. Pulvirenti F, Pecoraro A, Cinetto F, et al. Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency. Front Immunol 2018;9:2546. doi:10.3389/fimmu.2018. 02546
- 4. Gullo I, Costa C, Silva SL, et al. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer. Cells 2020;9(6):1498. doi:10.3390/cells906149810.3390/cells9061498734955232575504
- 5. Dhalla F, da Silva SP, Lucas M, et al. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011;165(1):1-7. doi:10.1111/j.1365-2249.2011. 04384.x
- 6. Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019;51(4):365-388. doi: 10.1055/a-0859-1883.10.1055/a-0859-188330841008